Chronic insomnia (insomnia disorder; difficulty initiating/maintaining sleep)
Sleep / behavioural · Geriatric & General
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Persistent difficulty with sleep initiation, maintenance or early waking despite adequate opportunity, with daytime impairment, for >=3 nights/week for >=3 months (chronic insomnia disorder). First-line treatment is cognitive behavioural therapy for insomnia (CBT-I), not drugs. Hypnotics (benzodiazepines, Z-drugs) should be short-term only due to tolerance, dependence, falls and cognitive harm, especially in older adults. Always identify and treat comorbid and secondary causes.
Red flags
- Insomnia with suicidal ideation or severe depression — assess and manage mental-health risk urgently
- Loud snoring + witnessed apnoeas + daytime somnolence — obstructive sleep apnoea (do not just sedate)
- Reduced need for sleep with elated mood/overactivity — mania
- Hypnotic dependence / escalating use / misuse
- Falls or confusion temporally related to hypnotics in an older adult
Assessment
Differential diagnosis
- Primary/chronic insomnia disorder
- Secondary: depression/anxiety, chronic pain, nocturia/BPH, GORD, heart failure/COPD (orthopnoea), restless legs syndrome, obstructive sleep apnoea
- Substance/drug-related: caffeine, alcohol, nicotine, stimulants, steroids, beta-agonists, SSRIs, decongestants; withdrawal states
- Circadian rhythm disorders (shift work, jet lag), poor sleep hygiene/environment
- Mania (reduced need for sleep), hyperthyroidism
Investigations
- Sleep history + sleep diary (2 weeks); bed partner account (snoring/apnoea, limb movements)
- Screen for depression/anxiety, pain, and substance use; medication review
- Screen for OSA (STOP-Bang, daytime somnolence) and restless legs; check ferritin (RLS)
- TFTs if clinically indicated; limited role for routine bloods
- Polysomnography only if OSA, periodic limb movement disorder or parasomnia suspected
Management
- Treat comorbidities and remove contributors: optimise pain, mood, nocturia, reflux, respiratory symptoms; review caffeine/alcohol/nicotine and culprit drugs
- Sleep hygiene education (necessary but not sufficient alone): consistent wake time, reduce screens/caffeine/alcohol, bedroom for sleep only, limit daytime napping, regular exercise (not late)
- CBT-I is first-line and most effective long-term: stimulus control, sleep restriction, cognitive restructuring, relaxation — refer/digital CBT-I
- Reserve hypnotics for short-term (<=2-4 weeks) use in severe/acute insomnia; use the lowest effective dose intermittently and counsel on tolerance/dependence, hangover sedation and falls
- Avoid benzodiazepines/Z-drugs in older adults where possible (falls, cognition, dependence — STOPP criteria)
- Consider melatonin (especially in adults >55 — prolonged-release) as a lower-risk option
- Deprescribe long-term hypnotics with a gradual taper and CBT-I support
- Review regularly; do not issue repeat hypnotic prescriptions without review
Drugs & doses
Short-term hypnotic (max 2-4 weeks, intermittent): zopiclone 3.75-7.5 mg PO at night (3.75 mg in elderly), or zolpidem 5-10 mg (5 mg elderly), or temazepam 10-20 mg PO at night [verify local dose]
Prolonged-release melatonin 2 mg PO at night for adults >=55 (up to 13 weeks); also used short-term in younger adults [verify local dose]
Avoid routine use of sedating antihistamines (promethazine, diphenhydramine) — anticholinergic, especially in elderly [verify local]
If insomnia is secondary to depression/anxiety, treat that (e.g. a sedating antidepressant such as mirtazapine 15 mg at night may help selected patients) [verify local dose]
Daridorexant / other orexin-receptor antagonists where available and recommended for chronic insomnia [verify local]
Disposition
Outpatient. Refer for CBT-I / digital CBT-I; sleep clinic if OSA or complex sleep disorder suspected; mental-health services if driven by depression/anxiety or risk.
Complications & pitfalls
- Hypnotic tolerance, dependence and rebound insomnia
- Falls, fractures, confusion/delirium and road-traffic accidents (especially elderly, residual sedation)
- Worsening mood, impaired daytime function and quality of life
- Masking of untreated OSA or depression
Exam pearls
- CBT-I — not hypnotics — is the first-line, evidence-based treatment for chronic insomnia and the only one effective long-term.
- Hypnotics are short-term bridges only; benzodiazepines and Z-drugs are high-risk in older adults (falls, cognition, dependence).
- Prolonged-release melatonin is a reasonable lower-risk option, especially over age 55.
- Always look for and treat a secondary cause — OSA, depression, pain, nocturia, RLS, caffeine/alcohol.
- Guidance: NICE CKS insomnia; use the lowest effective dose for the shortest time and deprescribe with a taper + CBT-I.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.